The Radiofrequency ablation device used by the Liver Tumor Ablation Program has FDA 510K marketing authorization. The FDA typically does not approve devices but authorizes them for marketing. Surgical are not approved in the same manner as medications.

No, ablation does not relate in any way to a coronary artery. Percutaneous Transluminal Coronary is the defining point to PTCA. Is the PTCA/Athr Intvl field tracking time between the last prior PTCA and CABG? So if a patient had a PTCA in 1984 and a CABG in 2000, would it be marked >6 hours? Or does this field pertain to PTCA/Ather Intvl during the admission of the CABG. Yes. Primary or direct stenting is done without angioplasty. All stent placement does not require angioplasty.

The Food & Drug Administration does not have an approval process for any nutritional supplements, only perscription medications. However, Flexcin is manufactured in a FDA inspected and approved facility.

The U. S. Congress passed the Dietary Supplement Health and Education Act (DSHEA) of 1994 which spells out the regulations as they apply to dietary supplements.

The price of the test is $200, including shipping costs. Payment can be made by any major credit card by the individual or by the ordering physician or clinic, by including the card details on the test request form. Samples submitted anonymously must be accompanied by a valid credit card number from the respective doctor or affiliated health care institution.

Currently, non-prescription nutritional supplements do not require FDA approval. However, BioVitale's Digestive Enzyme Complex is manufactured in a FDA monitored and approved facility under the highest quality control standards.

The anti-pathogenic and germicidal properties of the silver oxide in Safe Lips has been tested by 14 reputable and independent Contract Research Organizations (CROs). Countless individuals have contacted us with their very positive feedback, declaring the Safe Lips was the major factor in returning them to healthy skin. Furthermore, we have a very liberal return policy where customer satisfaction is 100% guaranteed, and yet we have experienced very few returns.

Yes, most of our users of the Quit Smoking Support System reported that they managed to stop smoking and no longer experienced cravings or withdrawal symptoms. Few smoking cessation products out there can make such similar claims in efficacy, ease, and successfulness.

ECP is approved by the FDA for the treatment of Angina and Congestive Heart Failure. It has undergone rigorous clinical trials at leading universities around the country and ECP has been the subject of scientific studies published in leading medical journals.

The US Food and Drug Administration (FDA) does not approve or disapprove of any kind of dietary supplements, such as Revivol ™, since it is not within their responsibility. The FDA only approves or disapproves of pharmaceutical drugs, which Revivol™ is not.

ZymaDerm is 'FDA Compliant' and conforms to the standards of the Homeopathic Pharacopeia of the United States (HPUS), a compendium recognized as both official and authoritative by the FDA. Each of the ingredients in ZymaDerm is stated in the Pharmacopeia to be useful as an aid in the treatment of skin rash conditions. If a drug-free agent is listed in the HPUS for treating certain conditions, a product containing that agent may be marketed for those conditions without specific FDA approval.

Our entire service has been scientifically reviewed for safety and effectiveness by the U.S. Food and Drug Administration (FDA). FDA granted Home Access Health nationwide clearance to market its service on April 28, 1999. The Home Access at-home telemedicine Hepatitis C counseling and testing service is the ONLY such service available in the United States approved by the U.S. Food and Drug Administration.

RFA has been used with success to treat primary liver cancer (otherwise known as hepatocellular carcinoma) and cancers that have spread to the liver from other places, such as colon cancer. Surgical resection of these tumors in carefully selected patients can lead to significant long-term survival but only a small percentage of these patients are candidates for surgery.

There are three basic types of systems used for RF ablation procedures. The specific RFA system and guidance method are chosen based on location and size of the tumor to be treated, proximity of large vessels, bleeding risk, the pathway that the needle-electrode has to take to enter the tumor, and the importance of minimizing collateral damage. The systems differ based on the length and configuration of the active tip of the needle-electrode.

Before the procedure, you will be asked to have nothing to eat or drink starting at midnight the evening before treatment. Your list of medications will be reviewed with our staff at the time of your consultation and you will be told which medications you may take in the morning of the procedure. If you are taking Coumadin, Plavix, or another blood thinner, you may need to stop taking that medication several days before the procedure.

Based on available data, outcomes appear to be excellent for patients with unresectable primary hepatocellular carcinoma. Reports show that well over 3,000 primary and metastatic liver tumors have been treated with RFA. These studies suggest that complete local response can be seen in 70-75% of patients with tumors ranging in diameter between 3 and 5 cm.

After the procedure, you may receive additional medication to prevent pain and nausea as the sedation wears off. Almost all of our patients are admitted overnight after the procedure to make sure that any pain is addressed with medication and to be certain that there are no post-procedure complications. You will need someone to take you home on the morning after the procedure. Once you arrive home, you can expect to have some mild post-procedure side effects.